Check out these articles for the latest in aging advances and research happening at the National Institute on Aging at NIH:
- NIH-funded translational research centers to speed, diversify Alzheimer’s drug discovery— NIA has launched two new research centers designed to diversify and reinvigorate the Alzheimer’s disease drug development pipeline.
- Hairpins, beta sheets and fuzzy coats: Tau structure comes into clearer focus— A common lab sampling tool was causing misunderstandings about the molecular shape of the protein tau. A team of NIA-supported scientists brought the problem into clearer focus in a study that could help advance research on Alzheimer’s and other neurodegenerative diseases.
- Winners announced for National Institute on Aging dementia care coordination challenge— Winners have been announced for the NIA Eureka competition awards, which focus on mobile apps for people with dementia, healthcare providers and caregivers.
- Blood test method may predict amyloid deposits in brain, potentially indicating Alzheimer’s disease— A research team supported in part by NIA developed a test method that can quantify beta-amyloid in blood samples.
- Frontotemporal lobar degeneration consortium combines and continues research efforts— The National Institute on Aging has merged two ongoing frontotemporal lobar degeneration (FTLD) studies to form a new, integrated consortium to advance the development of treatments.
- Cardiovascular health status at age 50 linked to dementia risk in later life— Better cardiovascular health at age 50 is associated with lower dementia risk in later life, suggests a study focusing on seven risk factors for heart disease and stroke.
- Could taking statins prevent dementia, disability?— The National Institute on Aging has funded a major study to examine the overall benefits and risks of drugs known as statins in 20,000 adults age 75 or older without heart disease.
Last Updated on April 29, 2020
